Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide

1 Dickstein K Cohen-Solal A Filippatos G McMurray JJ Ponikowski P Poole-Wilson PA ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29:2388–2442.

2 Levin ER Gardner DG Samson WK . Natriuretic peptides. N Engl J Med 1998; 339:321–328.

3 McCullough PA Nowak RM McCord J Hollander JE Herrmann HC Steg PG B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106:416–422.

4 Lubien E DeMaria A Krishnaswamy P Clopton P Koon J Kazanegra R Utility of B-natriuretic peptide in detecting diastolic dysfunction. Circulation 2002; 105:595–601.

5 Troughton RW Frampton CM Yandle TG Espiner EA Nicholls MG Richards AM . Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126–1130.

6 Weber M Hamm C . Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006; 92:843–849.

7 Heeschen C Hamm CW Mitrovic V Lantelme NH White HD , and for the PRISM Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes Circulation 2004; 110:3206–3212.

8 Richards AM Nicholls MG Espiner EA Lainchbury JG Troughton RW Elliott J B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107:2786–2792.

9 Kragelund C Gronning B Kober L Hildebrandt P Steffensen R . N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352:666–675.

10 McKelvie RS Teo KK Roberts R McCartney N Humen D Montague T Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). Am Heart J 2002; 144:23–30.

11 Passino C Severino S Poletti R Piepoli MF Mammini C Clerico A Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 2006; 47:1835–1839.

12 Lang RM Bierig M Devereux RB Flachskampf FA Foster E Pellikka PA Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440–1463.

13 American College of Sports Medicine (ACSM). Guidelines for exercise testing and prescription 7th ed. Baltimore: Lippincott Williams & Wilkins.

14 Leon AS Franklin BA Costa F Balady GJ Berra KA Stewart KJ ; American Heart Association; Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention); Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); American association of Cardiovascular and Pulmonary Rehabilitation. Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease: an American Heart Association Scientific Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation Circulation 2005; 111:369–376.

15 Karvonen MJ Kental E Mustal O . The effects of training on heart rate. Ann Med Exp et Biol Fenn 1957; 35:307.

16 Giallauria F Cirillo P Lucci R Pacileo M De Lorenzo A D'Agostino M Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Eur J Cardiovasc Prev Rehabil 2008; 15:113–118.

17 De Lemos JA McGuire DK Drazner MH . B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362:316–322.

18 Wang TJ Larson MG Levy D Benjamin EJ Leip EP Omland T Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655–663.

19 Bibbins-Domingo K Gupta R Na B Wu AHB Schiller NB Whooley MA . N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 2007; 297:169–176.

20 Groenning BA Raymond I Hildebrandt PR Nilsson JC Baumann M Pedersen F . Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004; 90:297–303.

21 Januzzi JL van Kimmenade R Lainchbury J Bayes-Genis A Ordonez-Llanos J Santalo-Bel M NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27:330–337.

22 Paulus WJ Tschöpe C Sanderson JE Rusconi C Flachskampf FA Rademakers FE How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28:2539–2550.

23 Corteville DCM Bibbins-Domingo K Wu AHB Ali S Schiller NB Whooley MA . N-Terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease. Arch Intern Med 2007; 167:483–489.

24 Logeart D Thabut G Jourdain P Chavelas C Beyne P Beauvais F Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43:635–641.

25 Caruana L Petrie MC Davie AP McMurray JJ . Do patients with suspected heart failure and preserved left ventricular systolic function suffer from diastolic heart failure or from misdiagnosis? A prospective descriptive study. BMJ 2000; 321:215–218.

26 Angeja BG Grossman W . Evaluation and management of diastolic heart failure. Circulation 2003; 107:659–663.

27 Giallauria F De Lorenzo A Pilerci F Manakos A Lucci R Psaroudaki M Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Eur J Cardiovasc Prev Rehabil 2006; 13:625–632.

28 Aurigemma GP Gaasch WH . Diastolic heart failure. N Engl J Med 2004; 351:1097–1105.

29 Jessup M Brozena S . Heart failure. N Engl J Med 2003; 348:2007–2018.

30 Pernenkil R Vinson JM Shah AS Beckham V Wittenberg C Rich MW . Course and prognosis in patients or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997; 79:216–219.

31 Smith GL Masoudi FA Vaccarino V Radford MJ Krumholz HM . Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 2003; 41:1510–1518.

32 Clark AL . Exercise and heart failure: assessment and treatment. Heart 2006; 92:699–703.

33 Rees K Taylor RS Singh S Coats AJS Ebrahim S . Exercise based rehabilitation for heart failure Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003331. doi: 10.1002/14651858.CD003331.pub2.

34 Belardinelli R Georgiou D Cianci G Purcaro A . Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 1999; 99:1173–1182.

35 Maria Sarullo F Pristina T Brusca I Milia S Raimondi R Sapeva M Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13:812–817.